Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Ropivacaine Hydrochloride Patent Expiration

Ropivacaine Hydrochloride is used for pain management. It was first introduced by Fresenius Kabi Usa Llc in its drug Naropin on Sep 24, 1996. 13 different companies have introduced drugs containing Ropivacaine Hydrochloride.


Ropivacaine Hydrochloride Patents

Given below is the list of patents protecting Ropivacaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Naropin US7857802 Connector for medical liquid-containing packages and medical liquid-containing packages Nov 28, 2026 Fresenius Kabi Usa
Naropin US7828787 Connector for packaging containing medical fluids and packaging for medical fluids Oct 18, 2025 Fresenius Kabi Usa
Naropin US8162915 Connector for packings containing medical liquids, and corresponding packing for medical liquids May 23, 2024

(Expired)

 Fresenius Kabi Usa
Naropin US8118802 Connector for packaging containing medical fluids and packaging for medical fluids May 18, 2023

(Expired)

 Fresenius Kabi Usa
Naropin US5670524 Methods and compositions for the treatment of pain utilizing ropivacaine Sep 23, 2014

(Expired)

 Fresenius Kabi Usa
Naropin US5834489 Methods and compositions for the treatment of pain utilizing ropivacaine May 26, 2014

(Expired)

 Fresenius Kabi Usa



Ropivacaine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ropivacaine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Ropivacaine Hydrochloride. The first generic version for Ropivacaine Hydrochloride was by Navinta Llc and was approved on Jul 17, 2014. And the latest generic version is by Hikma Pharmaceuticals Usa Inc and was approved on Aug 15, 2024.

Given below is the list of companies who have filed for Ropivacaine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. AMNEAL

Amneal Eu Ltd has filed for 4 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/100ML (5MG/ML)

solution Prescription INJECTION AP Mar 7, 2023
1GM/200ML (5MG/ML)

solution Prescription INJECTION AP Mar 7, 2023
400MG/200ML (2MG/ML)

solution Prescription INJECTION AP Mar 8, 2023
200MG/100ML (2MG/ML)

solution Prescription INJECTION AP Mar 8, 2023


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
Paterson Amneal Pharmaceuticals, Llc
Hauppauge Amneal Pharmaceuticals of New York, LLC
East Hanover Amneal Pharmaceuticals LLC
Piscataway Amneal Pharmaceuticals, LLC
Branchburg Amneal Pharmaceuticals, LLC
Glasgow Amneal Pharmaceuticals LLC
Bridgewater Amneal Complex Products Research LLC
Brookhaven Amneal Pharmaceuticals of New York, LLC
India
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Matoda Amneal Pharmaceuticals Private Ltd.
Hyderabad Amneal Oncology Private Limited





2. CAPLIN

Caplin Steriles Ltd has filed for 6 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Caplin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/20ML (5MG/ML)

solution Prescription INJECTION AP Apr 9, 2020
40MG/20ML (2MG/ML)

solution Prescription INJECTION AP Apr 9, 2020
150MG/30ML (5MG/ML)

solution Prescription INJECTION AP Apr 9, 2020
200MG/20ML (10MG/ML)

solution Prescription INJECTION AP Apr 9, 2020
200MG/100ML (2MG/ML)

solution Prescription INJECTION AP May 23, 2024
400MG/200ML (2MG/ML)

solution Prescription INJECTION AP May 23, 2024


Manufacturing Plant Locations
New

Caplin's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Caplin as present at those locations.

Country City Firm Name
United States
Creve Coeur Caplin, Dr David
India
Gummidipoondi Caplin Steriles Limited





3. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 7 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INJECTION AP Jul 13, 2016
150MG/20ML (7.5MG/ML)

solution Prescription INJECTION AP Jul 13, 2016
100MG/10ML (10MG/ML)

solution Prescription INJECTION AP Jul 13, 2016
40MG/20ML (2MG/ML)

solution Prescription INJECTION AP Jul 13, 2016
200MG/100ML (2MG/ML)

solution Prescription INJECTION AP Jul 13, 2016
100MG/20ML (5MG/ML)

solution Prescription INJECTION AP Jul 13, 2016
150MG/30ML (5MG/ML)

solution Prescription INJECTION AP Jul 13, 2016


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited
Riico Industrial Area EUGIA Pharma Specialities Limited
Pashamylaram Eugia Pharma Specialities Limited





4. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 2 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
400MG/200ML (2MG/ML)

solution Prescription INJECTION AP Aug 18, 2022
200MG/100ML (2MG/ML)

solution Prescription INJECTION AP Aug 18, 2022





5. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG/20ML (2MG/ML)

solution Prescription INJECTION AP Jul 20, 2020
200MG/20ML (10MG/ML)

solution Prescription INJECTION AP Jul 20, 2020
150MG/20ML (7.5MG/ML)

solution Prescription INJECTION AP Jul 20, 2020
150MG/30ML (5MG/ML)

solution Prescription INJECTION AP Jul 20, 2020
500MG/100ML (5MG/ML)

solution Prescription INJECTION AP Aug 15, 2024
400MG/200ML (2MG/ML)

solution Prescription INJECTION AP Aug 15, 2024
200MG/100ML (2MG/ML)

solution Prescription INJECTION AP Aug 15, 2024


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Cherry Hill Hikma Pharmaceuticals USA Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Dayton Hikma Injectables USA Inc
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





6. HOSPIRA

Hospira Inc has filed for 6 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/20ML (7.5MG/ML)

solution Discontinued INJECTION N/A Sep 23, 2014
20MG/10ML (2MG/ML)

solution Discontinued INJECTION N/A Sep 23, 2014
150MG/30ML (5MG/ML)

solution Discontinued INJECTION N/A Sep 23, 2014
100MG/10ML (10MG/ML)

solution Discontinued INJECTION N/A Sep 23, 2014
40MG/20ML (2MG/ML)

solution Discontinued INJECTION N/A Sep 23, 2014
200MG/20ML (10MG/ML)

solution Discontinued INJECTION N/A Sep 23, 2014


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Clayton Hospira, Inc.
Mcpherson Hospira, Inc., A Pfizer Company
Morgan Hill Hospira Inc
Rocky Mount Hospira, Inc.
Lake Forest Hospira Inc
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





7. INFORLIFE

Inforlife Sa has filed for 4 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Inforlife.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/100ML (2MG/ML)

solution Prescription INJECTION AP Jun 11, 2018
400MG/200ML (2MG/ML)

solution Prescription INJECTION AP Jun 11, 2018
500MG/100ML (5MG/ML)

solution Prescription INJECTION AP Jun 11, 2018
1GM/200ML (5MG/ML)

solution Prescription INJECTION AP Jun 11, 2018


Manufacturing Plant Locations
New

Inforlife's manufacturing plants are situated in 1 country - Switzerland. Given below are the details of these plant locations as well as the firm names of Inforlife as present at those locations.

Country City Firm Name
Switzerland
Campascio InfoRLife SA





8. KINDOS

Kindos Pharmaceuticals Co Ltd has filed for 7 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Kindos.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/30ML (5MG/ML)

solution Prescription INJECTION AP Jul 30, 2024
200MG/20ML (10MG/ML)

solution Prescription INJECTION AP Jul 30, 2024
100MG/20ML (5MG/ML)

solution Prescription INJECTION AP Jul 30, 2024
100MG/10ML (10MG/ML)

solution Prescription INJECTION AP Jul 30, 2024
150MG/20ML (7.5MG/ML)

solution Prescription INJECTION AP Jul 30, 2024
20MG/10ML (2MG/ML)

solution Prescription INJECTION AP Jul 30, 2024
40MG/20ML (2MG/ML)

solution Prescription INJECTION AP Jul 30, 2024


Manufacturing Plant Locations
New

Kindos's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Kindos as present at those locations.

Country City Firm Name
China
Chengdu Kindos Pharmaceuticals Co., Ltd.





9. MYLAN LABS LTD

Mylan Laboratories Ltd has filed for 2 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
400MG/200ML (2MG/ML)

solution Prescription INJECTION AP Oct 26, 2023
200MG/100ML (2MG/ML)

solution Prescription INJECTION AP Oct 26, 2023





10. NAVINTA LLC

Navinta Llc has filed for 2 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Navinta Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INJECTION AP Jul 17, 2014
150MG/30ML (5MG/ML)

solution Prescription INJECTION AP Jul 17, 2014





11. RISING

Rising Pharma Holdings Inc has filed for 6 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG/20ML (2MG/ML)

solution Discontinued INJECTION N/A Sep 23, 2014
150MG/30ML (5MG/ML)

solution Prescription INJECTION AP Apr 11, 2016
150MG/20ML (7.5MG/ML)

solution Discontinued INJECTION N/A Sep 23, 2014
200MG/20ML (10MG/ML)

solution Discontinued INJECTION N/A Sep 23, 2014
400MG/200ML (2MG/ML)

solution Prescription INJECTION AP Mar 16, 2018
200MG/100ML (2MG/ML)

solution Prescription INJECTION AP Mar 16, 2018


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Decatur Rising Pharma Holdings, Inc
Saddle Brook Rising Pharmaceuticals, Inc.
Rising Sun Rising Sun Veterinary Clinic
Fort Bragg Rising Tide Sea Vegetables
Mount Morris Rising Creek Bakery LLC
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Phoenix Rising Sun Farms Inc
East Brunswick Rising Pharma Holding, Inc.
Livingston Risingsun Iodine Products Corp.
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





12. SOMERSET THERAPS LLC

Somerset Therapeutics Llc has filed for 7 different strengths of generic version for Ropivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Somerset Theraps Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/10ML (10MG/ML)

solution Prescription INJECTION AP Jun 15, 2018
200MG/20ML (10MG/ML)

solution Prescription INJECTION AP Jun 15, 2018
20MG/10ML (2MG/ML)

solution Prescription INJECTION AP Jun 15, 2018
40MG/20ML (2MG/ML)

solution Prescription INJECTION AP Jun 15, 2018
100MG/20ML (5MG/ML)

solution Prescription INJECTION AP Jun 15, 2018
150MG/30ML (5MG/ML)

solution Prescription INJECTION AP Jun 15, 2018
150MG/20ML (7.5MG/ML)

solution Prescription INJECTION AP Jun 15, 2018